Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice
- PMID: 21904935
- PMCID: PMC3252460
- DOI: 10.1007/s11095-011-0580-9
Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice
Abstract
Purpose: To determine if fasting would affect the intestinal expression and in vivo functional activity of PEPT1 as determined after oral dosing of the dipeptide glycylsarcosine (GlySar).
Methods: Systemic exposure and tissue distribution studies were performed in wild-type and Pept1 knockout mice, under fed and fasted conditions, following both intravenous and oral doses of [(14)C]GlySar at 5 nmol/g body weight. Intestinal PEPT1 expression was evaluated by real-time PCR and immunoblot analyses.
Results: We found that expression of PEPT1 protein in the small intestine was increased ~2-fold in wild-type mice during fasted as compared to fed conditions. In agreement, systemic exposure and peak plasma concentrations of orally administered GlySar were 40 and 65% greater, respectively, in wild-type mice during fasted vs. fed state. No significant differences were observed between fed and fasted animals during PEPT1 ablation. Tissue distribution of GlySar was unchanged after oral dosing for all four treatment groups.
Conclusions: As little as 16 h of fasting can cause significant upregulation of PEPT1 protein expression in the small intestine, which then translates into a significant increase in in vivo oral absorption of GlySar.
Figures









Similar articles
-
Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice.Drug Metab Dispos. 2010 Oct;38(10):1740-6. doi: 10.1124/dmd.110.034025. Epub 2010 Jul 21. Drug Metab Dispos. 2010. PMID: 20660104 Free PMC article.
-
Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.Drug Metab Dispos. 2011 Dec;39(12):2250-7. doi: 10.1124/dmd.111.041087. Epub 2011 Aug 31. Drug Metab Dispos. 2011. PMID: 21880829 Free PMC article.
-
Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1.Mol Pharm. 2014 Oct 6;11(10):3737-46. doi: 10.1021/mp500497p. Epub 2014 Sep 2. Mol Pharm. 2014. PMID: 25148225 Free PMC article.
-
Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine.Mol Pharm. 2008 Nov-Dec;5(6):1122-30. doi: 10.1021/mp8001655. Mol Pharm. 2008. PMID: 19434858 Free PMC article.
-
Membrane transporters.Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S41-50. doi: 10.1016/s0928-0987(00)00163-9. Eur J Pharm Sci. 2000. PMID: 11033426 Review.
Cited by
-
Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.Drug Metab Dispos. 2013 Mar;41(3):608-14. doi: 10.1124/dmd.112.049239. Epub 2012 Dec 21. Drug Metab Dispos. 2013. PMID: 23264448 Free PMC article.
-
Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.Mol Aspects Med. 2013 Apr-Jun;34(2-3):323-36. doi: 10.1016/j.mam.2012.11.003. Mol Aspects Med. 2013. PMID: 23506874 Free PMC article. Review.
-
Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs).Pharmaceutics. 2023 Oct 23;15(10):2517. doi: 10.3390/pharmaceutics15102517. Pharmaceutics. 2023. PMID: 37896276 Free PMC article. Review.
-
Cross-species comparison of genes related to nutrient sensing mechanisms expressed along the intestine.PLoS One. 2014 Sep 12;9(9):e107531. doi: 10.1371/journal.pone.0107531. eCollection 2014. PLoS One. 2014. PMID: 25216051 Free PMC article.
-
Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.Compr Physiol. 2018 Mar 25;8(2):731-760. doi: 10.1002/cphy.c170032. Compr Physiol. 2018. PMID: 29687900 Free PMC article. Review.
References
-
- Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF, Hediger MA. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 1994;368:563–566. - PubMed
-
- Daniel H. Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol. 2004;66:361–384. - PubMed
-
- Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica. 2008;38:1022–1042. - PubMed
-
- Brandsch M, Knütter I, Bosse-Doenecke E. Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol. 2008;60:543–585. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials